Indication
The EMA label of Aimovig ® states approval for patients with at least 4 monthly migraine days.
Although the reimbursement criteria in Belgium are more limited, Aimovig ® is indicated for patients with at least 8 monthly...
The EMA label of Aimovig ® states approval for patients with at least 4 monthly migraine days.
Although the reimbursement criteria in Belgium are more limited, Aimovig ® is indicated for patients with at least 8 monthly...
* A total of n=4038 RRMS-approved DMT commencements recorded in Australian MSBase clinics between September 2011 and February 2016 were included in the analysis. 10. Spelman T et al. Poster 1193 Presented at ECTRIMS 2017. 12. For...
Stronger Heart: In PROVE-HF, LVEF increased from 28.2% to 37.8% in patients with HFrEF treated with ENTRESTO ® at 12 months (difference, 9.4% [95% CI, 8.8% to 9.9%]; P < .001).1 Stronger Life: In...
Cosentyx is approved in 7 indications 1 :
Adult plaque psoriasis
Cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy....
At Week 48, brolucizumab demonstrated non-inferiority to aflibercept in mean BCVA change from baseline in HAWK (p<0.001). • Visual acuity gains achieved at Week 48...